Science Explorer Back to mapMap
Discussion
Researcher · Isarna Therapeutics (Germany) · Germany

Michel Janicot

Michel Janicot publishes mostly in Molecular Biology, Oncology and Cancer Research, on topics such as TGF-β signaling in diseases, Histone Deacetylase Inhibitors Research and RNA Interference and Gene Delivery.

ORCID 0000-0002-4669-9641 OpenAlex
World rank
#1,527,039
of 7,710,434 ranked researchers
Rank in Germany
#75,286
of 364,343
Works
126
Citations
2.3k
Citations per work
18.6
h-index
26
i10-index 38Top 20% in Molecular Biology
Michel Janicot

What does Michel Janicot research?

Michel Janicot's work is mostly in Biochemistry, Genetics and Molecular Biology (58%), Medicine (10%), Immunology and Microbiology (4%).

Life Sciences: 79 works · 62.4% of their workBiochemistry, Genetics and Molecular Biology: 74 works · 58.5% of their workMolecular Biology: 61 works · 48.8% of their workCancer Research: 8 works · 6.3% of their workBiotechnology: 4 works · 3.4% of their workImmunology and Microbiology: 5 works · 3.9% of their workImmunology: 5 works · 3.9% of their workEverything else: 30 works · 23.6% of their workHealth Sciences: 13 works · 10.1% of their workMedicine: 13 works · 10.1% of their workOncology: 13 works · 10.1% of their workPhysical Sciences: 5 works · 3.9% of their workChemistry: 5 works · 3.9% of their workOrganic Chemistry: 5 works · 3.9% of their workTHEIR WORKMichel Janicot126works
Life Sciences62%Physical Sciences4%Health Sciences10%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology7458.5%
    2. Immunology and Microbiology53.9%
  2. Everything else3023.6%
    1. Medicine1310.1%
    1. Chemistry53.9%
  1. 1Molecular Biology49% of their works
  2. 2Oncology10% of their works
  3. 3Cancer Research6% of their works
  4. 4Organic Chemistry4% of their works
  5. 5Immunology4% of their works
  6. 6Biotechnology3% of their works

Research topics

Which keywords describe Michel Janicot's research?

The keywords of their largest research topics: Metastasis, Smad-dependent pathways, Tumor Suppression, Gene Expression, Gene Therapy, HDAC Inhibitors, Histone Deacetylases and BET Bromodomains.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Metastasis262 topics
  2. Smad-dependent pathways191 topic
  3. Tumor Suppression191 topic
  4. Gene Expression162 topics
  5. Gene Therapy152 topics
  6. HDAC Inhibitors91 topic
  7. Histone Deacetylases91 topic
  8. BET Bromodomains81 topic
  9. PROTACs81 topic
  10. RNA Interference81 topic
  11. siRNA Delivery81 topic
  12. Bacterial Therapy71 topic
  13. Cancer71 topic
  14. MicroRNA71 topic
  15. Tumor Targeting71 topic
  16. DNA nanotechnology61 topic
  17. Self-Assembly61 topic
  18. Breast Cancer51 topic
  19. HER251 topic

Where does Michel Janicot work?

Michel Janicot's main affiliation in the publication record is Isarna Therapeutics (Germany), Germany.

How many publications and citations does Michel Janicot have?

OpenAlex counts 126 works and 2,342 citations for Michel Janicot, an h-index of 26, ranking #1,527,039 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Michel Janicot

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Michel Janicot. Posts are plain text and can be reported.